ANEBULO PHARMACEUTICALS, INC. (ANEB) Operating cash flow 2021–2025
ANEBULO PHARMACEUTICALS, INC. (ANEB) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$6.3MFY2025 · since FY2021: -$4.9M → -$6.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$6.3M | +21.5% |
| FY2024 | -$8.1M | +16.4% |
| FY2023 | -$9.7M | -78.1% |
| FY2022 | -$5.4M | -11.6% |
| FY2021 | -$4.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More ANEB financial trends
ANEB RevenueANEB Net incomeANEB Net marginANEB Gross profitANEB Gross marginANEB Operating incomeANEB Operating marginANEB Free cash flowANEB Capital expendituresANEB Return on equityANEB Stock buybacksANEB Dividends paidANEB Total assetsANEB Total liabilitiesANEB Shareholders’ equityANEB overview →